Types of GLP-1 Six agents are available in the EU market but only 3 have reached the Egyptian market (Exenatide, Liraglutide and Dulaglutide)
This route can help: Deployed members who cannot easily reach a military facility (FormBlends works with pharmacies that can ship to APO and FPO addresses) Guard and Reserve members with TRICARE coverage gaps Veterans facing long VA specialty wait times Transitioning members who want continuity before TRICARE benefits end For compounded semaglutide or tirzepatide, FormBlends can help patients compare clinician-supervised compounded semaglutide and tirzepatide options

We also wish to thank Peter Ravn (MedImmune Ltd, Cambridge, UK) for intellectual input into GLP-1 analogue peptide stabilization, Bojana Popovic and Daniel Cannon (MedImmune Ltd, Cambridge, UK) for generating and analysing the peptide homology model, Adrian Podmore (MedImmune Ltd, Cambridge, UK) for conducting the aggregation and stability testing, Richard Kay (LGC, Fordham, UK) for conducting the mass spectrometry metabolites identification work, Marcella Petrone and John Hood (MedImmune Ltd, Cambridge, UK) for performing PK-PD simulations and analysis as well as Christopher Rhodes (MedImmune LLC, Gaithersburg, MD, USA) for his critical review of this manuscript
Several specific groups warrant additional consideration before starting or continuing treatment